ACS: Many Cancer Patients Face Lasting Financial Difficulties
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 28, 2024 -- Many patients with cancer diagnoses experience lasting financial difficulties, according to two studies presented at the annual meeting of the American College of Surgeons, held from Oct. 19 to 22 in San Francisco.
Jorge L. Gomez-Mayorga, M.D., from Beth Deaconess Medical Center in Boston, and colleagues conducted a difference-in-differences analysis comparing 99,175 individuals with cancer and 188,875 controls to examine financial outcomes after a cancer diagnosis. The researchers found that patients with cancer experienced increases in total collections, medical collections, and bankruptcy rates compared with controls, as well as decreases in credit scores. A decline in credit score was seen for survivors of bladder, liver, ovarian, colorectal, and lung cancers, which persisted for years after diagnosis, compared with a gradual increase in credit score seen in the control population.
Anastasia Bogdanovski, M.D., from Beth Deaconess Medical Center in Boston, and colleagues examined factors associated with financial toxicity in colorectal cancer patients in Massachusetts. The outcome credit score was assessed over time. Data were included for 7,227 colorectal cancer patients with median financial follow-up of 5.3 years. The researchers found that the mean credit score was 716 points, with significant variation seen in points: −11 for younger than 62 years; −78 and −62 for Black and Hispanic race, respectively; −28 for unmarried; −14 for Area Deprivation Index below median; −5 for nonhomeowner; −18 for income below median of $52,000; and −10 and −7 for distant or regional disease, respectively. Notable disparities were observed among cancer and treatment types.
"Further research is needed, but I think financial security should be a priority in cancer care," coauthor from both studies Benjamin C. James, M.D., also from Beth Israel Deaconess Medical Center, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals
FRIDAY, May 16, 2025 -- Short-term testosterone use among transmasculine and gender diverse (TMGD) individuals is not associated with an increased risk for gynecological cancers...
Increases in Incidence Rates of Some Cancers Seen in Early-Onset Age Groups
THURSDAY, May 15, 2025 -- The incidence rates of 14 cancers have increased in early-onset age groups, with increases in older-onset age groups also occurring in most of these...
Aqueous Humor Liquid Biopsy Safe in Pediatric Retinoblastoma
WEDNESDAY, May 14, 2025 -- For pediatric patients with retinoblastoma, aqueous humor liquid biopsy via anterior chamber paracentesis is a safe and well-tolerated procedure...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.